Rising Investments by the Government in R&D Activities is Expected to Elevate the Growth of the Global DNA Methylation market

 DNA methylation is a biological process that occurs by the addition of a methyl to the DNA molecule without changing the sequences of the nucleotides.

The Global DNA Methylation market is anticipated to grow at an astronomical rate in the forecasted timeline. The market growth is attributed to growing incidences of cancer cases, rising healthcare expenditure on infrastructural development and surging use of early-stage biomarkers in cancer profiling. Apart from this, escalating funding into research and development for the development of innovative product and rising government agency approval on new cancer therapies are anticipated to place a positive impact towards the growth of the market in the forthcoming years.

Based on Technology, Polymerase Chain Reaction (PCR) is expected to register fastest growth in the Global DNA Methylation market in 2019. PCR detect changes in DNA methylation and is used to make millions to billions of copies of a specific DNA sample in medical laboratory research and clinical techniques for detection of bacteria or viruses (particularly AIDS) and diagnosis of genetic disorders.

 

Based on Region, North America grabbed the highest market share in 2019. US dominated the North America segment. This is due to robust developments in healthcare infrastructure, surging number of Colorectal cancer (CRC) cases and rising investments by the government in R&D of products by industries. Along with this, strong footing of giant market players, burgeoning demand for protein expression systems and escalating ageing population that can lead to individuals developing cancer due to change in DNA Methylation. 

The key players with a considerable market share in the Global DNA Methylation market are Abcam PLC, Active Motif, Inc, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Diagenode Diagnostics S.A., EpiGentek Group Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, New England Biolabs, Inc., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Zymo Research Corporation etc.